Insider Shareholders with Direct Ownership of Crispr Therapeutics Ag (CRSP)
This section provides a comprehensive overview of the insiders with direct ownership of Crispr Therapeutics Ag (CRSP). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CRISPR Therapeutics AG Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals (Europe) Ltd
> 10% Shareholder |
130,940 | 0 | 5,380,940 $258 Million | 4 |
Dec 27, 2018
Added 0.51%
|
|
Celgene Corp /De/
> 10% Shareholder |
4,834,980 | 0 | 4,834,980 $231 Million | 1 |
Oct 24, 2016
Added 14.2%
|
|
Hadley Harbor Master Investors (Cayman) L.P.
> 10% Shareholder |
744,380 | 0 | 744,380 $35.6 Million | 1 |
Oct 24, 2016
Added 50.0%
|
|
Rodger Novak
President |
535,885 | 1,177,883 | 573,007 $27.4 Million | 68 |
Jun 30, 2021
Reduced 4.18%
|
|
Sven Ante Lundberg
Chief Scientific Officer |
55,217 | 0 | 505,217 $24.2 Million | 1 |
Oct 24, 2016
Added 9.85%
|
|
Samarth Kulkarni
Chief Executive Officer |
1,074,544 | 925,882 | 196,540 $9.41 Million | 120 |
Nov 11, 2024
Reduced 3.38%
|
|
James R. Kasinger
General Counsel and Secretary |
117,381 | 56,695 | 62,597 $3 Million | 29 |
Oct 14, 2024
Reduced 1.71%
|
|
Tony W Ho
Executive VP, Head of R&D |
146,467 | 84,470 | 52,364 $2.51 Million | 19 |
Dec 06, 2021
Reduced 19.4%
|
|
Lawrence Otto Klein
CBO & COO |
296,844 | 270,037 | 26,797 $1.28 Million | 26 |
Mar 14, 2022
Reduced 4.39%
|
|
Tyler Dylan Hyde
Chief Legal Officer |
45,000 | 225,000 | 25,204 $1.21 Million | 22 |
Jan 16, 2018
Reduced 44.11%
|
|
Julianne Bruno
Chief Operating Officer |
7,000 | 3,366 | 6,745 $322,950 | 2 |
Jun 21, 2024
Reduced 33.29%
|
|
Raju Prasad
Chief Financial Officer |
10,000 | 3,524 | 6,476 $310,070 | 2 |
Mar 15, 2024
Reduced 35.24%
|
|
Thomas Woiwode
Director |
12,241 | 6,612 | 5,629 $269,516 | 6 |
May 08, 2018
Reduced 22.7%
|
|
Brendan Smith
Chief Financial Officer |
7,575 | 2,503 | 5,072 $242,847 | 4 |
Feb 21, 2023
Reduced 21.53%
|
|
Phuong Khanh Morrow
Chief Medical Officer |
6,938 | 2,527 | 4,411 $211,198 | 2 |
May 24, 2023
Reduced 36.42%
|
|
Michael John Tomsicek
Chief Financial Officer |
51,833 | 50,352 | 1,891 $90,541 | 8 |
Aug 06, 2021
Reduced 76.0%
|
| 256 | 0 | 256 $12,257 | 2 |
Aug 13, 2020
Added 18.21%
|
|
|
Bradley J Ph D Bolzon
Director |
220,642 | 187,642 | 0 $0 | 19 |
Jun 29, 2021
Reduced 100.0%
|
|
Pablo J Cagnoni
Director |
30,000 | 30,000 | 0 $0 | 10 |
Nov 19, 2019
Reduced 100.0%
|